Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
86%(6 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
3
38%
Ph early_phase_1
1
13%
Ph phase_2
4
50%

Phase Distribution

1

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
4(50.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 24 (50.0%)
N/A3 (37.5%)

Trials by Status

completed788%
terminated113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8